$238 Million is the total value of Athyrium Capital Management, LP's 11 reported holdings in Q4 2022. The portfolio turnover from Q3 2022 to Q4 2022 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| AMYT | Amryt Pharma PLCsponsored ads | $64,658,056 | +5.5% | 8,857,268 | 0.0% | 27.18% | +18.4% | |
| Biora Inc.note 7.250% 12/0 | $56,262,773 | -10.4% | 103,500,000 | 0.0% | 23.65% | +0.6% | ||
| Buy | Omeros Corpnote 5.250% 2/1 | $31,700,772 | +41.9% | 58,131,000 | +44.8% | 13.32% | +59.3% | |
| Omeros Corpnote 6.250%11/1 | $20,240,546 | +5.2% | 21,005,000 | 0.0% | 8.51% | +18.0% | ||
| OSMT | RVL PHARMACEUTICALS PLC | $16,352,497 | -46.7% | 14,600,444 | 0.0% | 6.87% | -40.1% | |
| CMAX | CAREMAX INC | $16,305,349 | -48.5% | 4,467,219 | 0.0% | 6.85% | -42.2% | |
| Paratek Pharmaceuticals Inc.note 4.750% 5/0 | $8,213,010 | +2.7% | 9,000,000 | 0.0% | 3.45% | +15.2% | ||
| BridgeBio Pharma Inc.note 2.250% 2/0 | $7,753,900 | -11.1% | 20,000,000 | 0.0% | 3.26% | -0.2% | ||
| PBYI | PUMA BIOTECHNOLOGY INC | $7,580,642 | +78.5% | 1,792,114 | 0.0% | 3.19% | +100.3% | |
| PROG | Buy | Biora Inc. | $5,579,088 | -61.5% | 42,362,097 | +41.9% | 2.34% | -56.8% |
| REPH | Societal CDMO Inc. | $3,281,606 | -8.6% | 2,202,420 | 0.0% | 1.38% | +2.5% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-02-14
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| Amryt Pharma PLC | 10 | Q1 2023 | 46.3% |
| Progenity Inc. | 9 | Q4 2022 | 69.2% |
| Progenity Inc. | 8 | Q3 2023 | 39.2% |
| RVL PHARMACEUTICALS PLC | 8 | Q3 2023 | 11.5% |
| Societal CDMO Inc. | 8 | Q4 2022 | 3.1% |
| Omeros Corp | 7 | Q3 2023 | 39.3% |
| CAREMAX INC | 7 | Q4 2022 | 27.5% |
| Omeros Corp | 7 | Q3 2023 | 9.9% |
| PUMA BIOTECHNOLOGY INC | 7 | Q3 2023 | 4.2% |
| AEGERION PHARMACEUTICALS INC | 6 | Q1 2019 | 88.7% |
View Athyrium Capital Management, LP's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| PROGENITY, INC. | August 27, 2021 | 4,211,977 | 2.7% |
View Athyrium Capital Management, LP's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR/A | 2023-05-16 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
| 13F-HR | 2022-05-16 |
| 13F-HR | 2022-02-14 |
View Athyrium Capital Management, LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.